Selank peptide research compound
Back to Articlespeptides

Selank Peptide: Complete Guide to the Anxiety Research Peptide

Scientific Aminos Research TeamOctober 17, 202512 min

A comprehensive guide to Selank, the synthetic peptide studied for anxiolytic and nootropic effects, including mechanism of action, research findings, and comparison to Semax.

Selank Peptide: Complete Guide

Research Disclaimer
This article is for educational and research purposes only. The information provided does not constitute medical advice. Consult qualified healthcare professionals before making any health-related decisions.

Quick Facts

PropertyDetails
Full NameSelank (TP-7)
SequenceThr-Lys-Pro-Arg-Pro-Gly-Pro
Amino Acids7
OriginTuftsin analog + Pro-Gly
DeveloperInstitute of Molecular Genetics, Russia
Primary EffectsAnxiolytic, nootropic
AdministrationIntranasal, subcutaneous
StatusApproved in Russia, research elsewhere

Table of Contents

  1. Introduction
  2. What is Selank
  3. Mechanism of Action
  4. Research Findings
  5. Selank vs Semax
  6. Administration
  7. Potential Side Effects
  8. Frequently Asked Questions
  9. Conclusion

Introduction

Selank is a synthetic peptide developed in Russia for anxiety and cognitive research. As a tuftsin analog, it combines immunomodulatory properties with anxiolytic effects, making it unique among nootropic peptides.

This guide examines Selank's mechanisms, research findings, and how it compares to related peptides like Semax.

Note: Selank is a research peptide not approved by the FDA for any indication. This article presents research findings for educational purposes.


What is Selank

Origin and Development

Selank was developed at the Institute of Molecular Genetics (Russian Academy of Sciences) by combining:

  1. Tuftsin (Thr-Lys-Pro-Arg) - Immunomodulatory tetrapeptide
  2. Pro-Gly-Pro - Stabilizing sequence

Structure

Selank: Thr-Lys-Pro-Arg-Pro-Gly-Pro

Comparison to parent compounds:
Tuftsin:  Thr-Lys-Pro-Arg
Selank:   Thr-Lys-Pro-Arg-Pro-Gly-Pro
                        ↑
                  Added for stability

Key Characteristics

PropertyDetails
Molecular Weight~751 Da
StabilityMore stable than tuftsin
Half-lifeMinutes (peptide)
SolubilityWater-soluble
Storage-20°C lyophilized

Regulatory Status

RegionStatus
RussiaApproved anxiolytic
USAResearch compound (not FDA approved)
EuropeResearch compound
CanadaResearch compound

Mechanism of Action

Primary Mechanisms

Selank works through multiple pathways:

1. GABA System Modulation

  • Enhances GABA-ergic transmission
  • Allosteric modulation of GABA-A receptors
  • Does not bind benzodiazepine site
  • Non-sedating anxiolytic effect

2. Monoamine Effects

NeurotransmitterEffect
SerotoninModulates metabolism
DopamineInfluences levels
NorepinephrineAffects signaling

3. BDNF Expression

  • Increases Brain-Derived Neurotrophic Factor
  • Supports neuroplasticity
  • May enhance learning and memory
  • Neuroprotective potential

4. Gene Expression

Selank has been shown to affect expression of:

  • Anxiety-related genes
  • Immune-related genes
  • Neurotrophic factors

Immunomodulatory Effects

From its tuftsin heritage:

  • Modulates cytokine balance
  • Affects T-cell function
  • Anti-inflammatory properties
  • May support immune regulation

Mechanism Summary

Selank Administration
        ↓
┌───────┴───────┐
│               │
GABA-ergic      Monoamine
Modulation      Effects
    ↓               ↓
Anxiolytic      Mood/Cognition
Effects         Enhancement
        ↓
┌───────┴───────┐
│               │
BDNF            Immune
Expression      Modulation
    ↓               ↓
Neuroplasticity Anti-inflammatory

Research Findings

Anxiety Research

Animal Studies:

ModelFindings
Elevated plus mazeReduced anxiety behaviors
Open fieldIncreased exploration
Stress modelsImproved stress response
Learned helplessnessProtective effects

Human Research (Russian):

  • Anxiolytic effects reported
  • Comparable to benzodiazepines in some measures
  • Without sedation or dependence
  • Approved for clinical use in Russia

Cognitive Research

Findings:

  • Memory enhancement in animal models
  • Improved learning in stress conditions
  • Attention modulation
  • Neuroprotective effects

Proposed Cognitive Benefits:

  • Working memory support
  • Stress-resilient cognition
  • Focus enhancement
  • Memory consolidation

Immunomodulatory Research

Observations:

  • Cytokine balance modulation
  • T-cell activity effects
  • Anti-inflammatory properties
  • Potential autoimmune applications (research)

Comparison to Benzodiazepines

FactorSelankBenzodiazepines
AnxiolyticYesYes
SedationNoYes
DependenceNot reportedYes
Cognitive impairmentNoYes
ToleranceNot significantYes
MechanismMultiple pathwaysGABA-A specific

Selank vs Semax

Overview Comparison

PropertySelankSemax
OriginTuftsin analogACTH fragment
Primary effectAnxiolyticCognitive enhancer
Sequence7 amino acids7 amino acids
DeveloperSame instituteSame institute
AdministrationNasal/injectionNasal/injection

Mechanism Differences

Selank:

  • GABA modulation primary
  • Anxiolytic focus
  • Immunomodulatory
  • Calming effect

Semax:

  • BDNF/NGF primary
  • Cognitive focus
  • Neuroprotective
  • Stimulating effect

Effects Comparison

EffectSelankSemax
Anxiety reduction●●●●●●●●○○
Cognitive enhancement●●●○○●●●●●
Stimulation●○○○○●●●○○
Calming●●●●●●●○○○
Neuroprotection●●●○○●●●●○
Immune modulation●●●●○●●○○○

Which to Choose

Choose Selank for:

  • Primary anxiety focus
  • Stress reduction
  • Calm without sedation
  • Immune support interest
  • Sleep issues related to anxiety

Choose Semax for:

  • Cognitive enhancement focus
  • Focus and attention
  • Neuroprotection
  • Depression (research)
  • Mental clarity

Consider Both:

  • Some use both for complementary effects
  • Selank for calm, Semax for cognition
  • Research interest in combination

Administration

Intranasal Administration

Most common method:

FactorDetails
ConcentrationTypically 0.1% solution
Dose200-400mcg per dose
Frequency1-3x daily
DurationCycles of 2-4 weeks

Technique:

  1. Tilt head slightly forward
  2. Insert tip just inside nostril
  3. Spray while inhaling gently
  4. Alternate nostrils
  5. Avoid blowing nose immediately

Subcutaneous Injection

Alternative administration:

FactorDetails
Dose250-500mcg
Frequency1-2x daily
LocationAbdomen, arm
DurationSimilar cycling

Reconstitution (If Applicable)

For lyophilized powder:

  • Use bacteriostatic water
  • Calculate concentration
  • Store refrigerated
  • Use within 2-4 weeks

Cycling Recommendations

ApproachProtocol
Conservative2 weeks on, 1 week off
Standard3-4 weeks on, 1-2 weeks off
AssessmentStart low, evaluate response

Potential Side Effects

Reported Side Effects

Side EffectFrequencyNotes
Nasal irritationCommonWith intranasal use
FatigueOccasionalUsually initial
HeadacheRareTypically mild
Allergic reactionRareDiscontinue if occurs

Safety Profile

Based on available research:

  • Generally well-tolerated
  • No significant CNS depression
  • No dependence reported
  • No cognitive impairment
  • Minimal drug interactions known

Contraindications (Proposed)

  • Known peptide allergies
  • Pregnancy/breastfeeding (unstudied)
  • Severe immunocompromise (theoretical)
  • Concurrent benzodiazepine use (unknown interactions)

Comparison to Standard Anxiolytics

FactorSelankBenzodiazepinesSSRIs
Addiction potentialNone reportedHighLow
SedationNoneHighVariable
OnsetFastFastWeeks
ToleranceNot significantDevelopsNot significant
WithdrawalNot reportedSignificantPossible

Frequently Asked Questions

How quickly does Selank work?

Effects may be noticed within minutes to hours after administration, unlike SSRIs which take weeks. Optimal effects may develop over days of consistent use.

Is Selank addictive?

No addiction or dependence has been reported in available research, unlike benzodiazepines.

Can Selank be used with other nootropics?

Combinations are sometimes used but lack formal study. Common stacks include Selank with Semax. Caution with other GABA-ergic substances.

How does Selank compare to prescription anxiolytics?

Selank shows anxiolytic effects in research without the sedation, dependence, or cognitive impairment of benzodiazepines. However, it lacks FDA approval and extensive Western clinical trials.

What's the difference between Selank and NA-Selank?

NA-Selank (N-Acetyl Selank) is an acetylated form claimed to have improved stability and potency. Limited comparative research exists.

In most countries, Selank is legal to purchase for research purposes. It's not a controlled substance but is not approved for human medical use outside Russia.

How should Selank be stored?

Lyophilized: -20°C for long-term Reconstituted: 2-8°C, use within 2-4 weeks Protect from light and moisture

Can Selank help with social anxiety?

Some research suggests anxiolytic effects that could apply to social anxiety, though specific studies on social anxiety are limited.


Conclusion

Selank represents an interesting approach to anxiety research, combining anxiolytic effects with immunomodulatory properties. Its mechanism differs substantially from traditional anxiolytics, potentially offering benefits without typical side effects.

Summary

AspectAssessment
MechanismMulti-target (GABA, monoamines, BDNF)
Primary useAnxiolytic research
Research levelModerate (more needed outside Russia)
Safety profileFavorable in available research
ComparisonDifferent from but complementary to Semax

Key Points

  1. Developed from tuftsin with added stability
  2. Anxiolytic without sedation or dependence (research)
  3. Multiple mechanisms beyond GABA alone
  4. Immunomodulatory properties from tuftsin heritage
  5. Research compound outside Russia

Research Needs

  • More Western clinical trials
  • Long-term safety data
  • Standardized protocols
  • Comparative studies
  • Combination research

Selank remains an active area of nootropic and anxiolytic research with promising early findings.


References

  1. Semenova TP, et al. Effects of Selank on cognitive processes after damage to the cerebral catecholamine system during early ontogenesis. Bull Exp Biol Med. 2009.

  2. Zozulya AA, et al. The anxiolytic effect of Selank. Bull Exp Biol Med. 2001.

  3. Kozlovskii II, et al. Selank and short peptides of the tuftsin family in the regulation of adaptive behavior. Neurosci Behav Physiol. 2003.

  4. Uchakina ON, et al. Immunomodulatory effects of Selank. Bull Exp Biol Med. 2008.

  5. Seredenin SB, et al. Selank peptide derivative with anxiolytic activity. Vopr Med Khim. 1998.

  6. Kolik LG, et al. Comparison of Selank anxiolytic action with benzodiazepine effects. Bull Exp Biol Med. 2014.


Last updated: March 12, 2026
Reviewed by: Scientific Aminos Editorial Board
Share this article

Reviewed by: Dr. Research Reviewer, PhD